Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNP | P00491 | 6/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.42 |
| ▸ | FGFR2 | P21802 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10421279 | 0.90 | PNP (0.54) | PNPKDM4EMEN1ALDH1A1MAPT | |
| SCHEMBL2343355 | 0.84 | PNP (0.59) | PNPKDM4EMEN1ALDH1A1MAPT | |
| SCHEMBL37957 | 0.82 | PNP (0.53) | PNPKDM4EMEN1ALDH1A1MAPT | |
| SCHEMBL874735 | 0.82 | PNP (0.66) | PNPKDM4EMEN1ALDH1A1MAPT | |
| SCHEMBL667795 | 0.80 | PNP (0.61) | PNPKDM4EMEN1ALDH1A1MAPT | |
| SCHEMBL5935062 | 0.79 | PNP (0.70) | PNPKDM4EMEN1ALDH1A1MAPT | |
| SCHEMBL9960811 | 0.79 | PNP (0.71) | PNPKDM4EMEN1ALDH1A1MAPT | |
| SCHEMBL4730342 | 0.78 | FGFR1 (0.34) | PNPFGFR1FGFR2 | |
| SCHEMBL6268782 | 0.77 | PNP (0.50) | PNPKDM4EMEN1ALDH1A1MAPT | |
| SCHEMBL6272728 | 0.77 | PNP (0.58) | PNPKDM4EMEN1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021222988-A1 | CELL ENTRY-MODULATING AGENTS AND USES THEREFOR | GRIFFITH UNIVERSITY (AU) | 2021-11-11 | — | — | WO | disclosed |
| WO-2012078637-A2 | COMPOSITION AND METHOD FOR OLIGONUCLEOTIDE DELIVERY | IMMUNE DISEASE INSTITUTE, INC. (US) | 2012-06-14 | — | — | WO | disclosed |
| WO-2011056630-A2 | SMALL MOLECULE INHIBITORS OF HEPATITIS C VIRUS | TRUSTEES OF BOSTON UNIVERSITY (US) | 2011-05-12 | — | — | WO | disclosed |
| EP-2205294-A2 | IMMOBILIZED BIOLOGICALLY ACTIVE ENTITIES HAVING A HIGH DEGREE OF BIOLOGICAL ACTIVITY | Gore Enterprise Holdings, Inc. (US) | 2010-07-14 | — | — | EP | disclosed |
| WO-2009064372-A2 | IMMOBILIZED BIOLOGICALLY ACTIVE ENTITIES HAVING A HIGH DEGREE OF BIOLOGICAL ACTIVITY | GORE ENTERPRISE HOLDINGS, INC. (US) | 2009-05-22 | — | — | WO | disclosed |